Estimation of Individual Positive Anti-Islet Autoantibodies from 3 Screen ICA Titer

Area of Science:

• Immunology
• Endocrinology
• Diabetes Research

Background:

• The 3 Screen ICA ELISA simultaneously measures autoantibodies to GAD, IA-2, and ZnT8, crucial for type 1 diabetes screening.
• However, it does not identify individual positive autoantibodies.

Purpose of the Study:

• To estimate individual autoantibody positivity based on the 3 Screen ICA titer in type 1 diabetes patients.
• To analyze the sensitivity and contribution rates of individual autoantibodies across different 3 Screen ICA titer groups.

Main Methods:

• Cross-sectional study of 617 type 1 diabetes patients.
• Simultaneous measurement of 3 Screen ICA and individual autoantibodies (GADA, IA-2A, ZnT8A).
• Patients grouped by 3 Screen ICA titer to examine autoantibody prevalence and associations.

Main Results:

• 69% of patients had 3 Screen ICA titers above the 99th percentile cutoff (20 index).
• Prevalence of GADA ranged from 80-100% with higher titers; 97% positive at ≥300 index.
• Positive associations found between specific 3 Screen ICA titer ranges and combinations of individual autoantibodies, including GADA, IA-2A, and ZnT8A.

Conclusions:

• The 3 Screen ICA titer can be a useful indicator for estimating individual autoantibody status in type 1 diabetes.
• This estimation aids in understanding the autoimmune profile and potentially refining diagnostic strategies.